跳至主要内容
临床试验/DRKS00006272
DRKS00006272已完成未知

Changes of the mRNA and microRNA expression profile of individuals with metabolic syndrome after lifestyle-induced weight loss - DIABOWLT (DIABetes Obesity Weight Loss Trial)

Institut für Klinische Chemie und Pathobiochemie Otto-von-Guericke Universität Magdeburg0 个研究点目标入组 74 人开始时间: 2014年7月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
40 Years 至 55 Years(—)
性别
Male

入选标准

  • 1. metabolic syndrome with abdominal obesity (waist circumference > 102 cm)
  • 2. meet two additional criteria for metabolic syndrome as defined by national Cholesterol Education Program Adult Treatmen Panel III guideliens:
  • - fasting TG conc. > 150 mg/dl
  • - HDL-C < 40 mg/dl
  • - fasting glucose > 110 mg/dl
  • - high blood pressure >140 mmHg systolic and /or > 90 mmHg diastolic or current treatment by anti-hypertensive medication

排除标准

  • 1. Smoking
  • 2. surgical procedure for weight loss within the previous 6 month
  • 3. uncontrolled diabetes (HbA1c > 10%)
  • 4. severe renal dysfunction (creatinin concentration > 2.0 mg/dl)
  • 5. active liver disease
  • 6. obesity of known endocrine origin
  • 7. significant haematology abnormalities
  • 8. not able to walk at least 30 minutes per day

研究者

发起方
Institut für Klinische Chemie und Pathobiochemie Otto-von-Guericke Universität Magdeburg

相似试验